XORTX Therapeutics (XRTX) Depreciation & Amortization (CF) (2020 - 2026)
XORTX Therapeutics (XRTX) posted Depreciation & Amortization (CF) of $14,680 for the quarter ended Jun 30, 2026, down 29.6% from $20,841 a year earlier and down 34.4% from the prior quarter.
XORTX Therapeutics (XRTX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at XORTX Therapeutics was $108,875, down 1.4% year-over-year; for the year ended Dec 31, 2025, it was $112,115, down 4.4% from the prior year.
- Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 49.0% (years ended Dec 2020 to Dec 2025).
- In prior years, XORTX Therapeutics' Depreciation & Amortization (CF) was $117,274 in the year ended Dec 31, 2024 (-16.0%), $139,694 in the year ended Dec 31, 2023 (+140.2%), $58,146 in the year ended Dec 31, 2022 (+307.6%) and $14,266 in the year ended Dec 31, 2021 (-6.5%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Depreciation & Amortization (CF) since the quarter ended Mar 31, 2022.
- On a year-over-year basis, Depreciation & Amortization (CF) increased in three of the last eight quarters, with an average decline of 7.6%.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was the quarter ended Dec 31, 2022, with growth of 473.1%; the weakest was the quarter ended Sep 30, 2023, with a decline of 83.8%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $22,385 (quarter ended Mar 31, 2026), $48,922 (quarter ended Dec 31, 2025) and $22,888 (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | XORTX Therapeutics | 1.60 Mn | -1.70 Mn | - | 14,680.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,680.00 |
| Mar 31, 2026 | 22,385.00 |
| Dec 31, 2025 | 48,922.00 |
| Sep 30, 2025 | 22,888.00 |
| Jun 30, 2025 | 20,841.00 |
| Mar 31, 2025 | 19,464.00 |
| Dec 31, 2024 | 50,583.00 |
| Sep 30, 2024 | 19,560.00 |
| Jun 30, 2024 | 26,885.00 |
| Mar 31, 2024 | 20,246.00 |
| Dec 31, 2023 | 84,931.00 |
| Sep 30, 2023 | 18,329.00 |
| Jun 30, 2023 | 18,329.00 |
| Mar 31, 2023 | 18,105.00 |
| Dec 31, 2022 | 21,544.88 |
| Sep 30, 2022 | 113,336.60 |
| Mar 31, 2022 | 3,774.48 |
| Dec 31, 2021 | 3,759.62 |
| Mar 31, 2021 | 3,353.18 |
| Dec 31, 2020 | 3,942.66 |
XORTX Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();